Jonathan Himmelfarb is the Joseph W. Eschbach endowed chair in kidney research, director of the Kidney Research Institute, professor of medicine at the…
Read Full Bio
Patient Care Philosophy
As a physician, the total patient experience is my primary concern. I provide care that is personal and friendly. I am dedicated to educating the patient about health needs and empowering the patient to be actively involved their care. I strive to be a partner in health.
Clinical and translational kidney research
- Oxidative stress and inflammation in chronic kidney disease
- Biomarkers of cardiovascular risk in kidney disease
- Dialysis vascular access
- Mechanisms of proteinuria
|George Washington University||Medical education||1983
|Brigham and Women's Hospital||Fellowship||
|Maine Medical Center||Fellowship||
|Maine Medical Center||Internship||
|Maine Medical Center||Residency||
|Univ. of Vermont-Fletcher Allen||Teaching Appointment||
|American Board of Internal Medicine||Nephrology||1988
|American Board of Internal Medicine||General Internal Medicine||1986
Jonathan Himmelfarb is the Joseph W. Eschbach endowed chair in kidney research, director of the Kidney Research Institute, professor of medicine at the University of Washington, and the president-elect of the American Society of Nephrology.
Dr. Himmelfarb's research interests involve metabolic complications of kidney disease including CKD, ESRD and AKI. In particular, he has focused on understanding how the loss of kidney function contributes to increased oxidative stress, inflammation, insulin resistance and endothelial dysfunction, and ultimately cardiovascular risk in kidney disease. Dr. Himmelfarb has also been involved in creating statewide, community-based research into healthcare disparities related to chronic kidney disease. He evaluates novel approaches to renal replacement therapies.